Details for Patent: 8,299,052

Which drugs does patent 8,299,052 protect, and when does it expire?

Patent 8,299,052 protects MOXATAG and is included in one NDA.

This patent has eleven patent family members in six countries.

Summary for Patent: 8,299,052

Title:	Pharmaceutical compositions and methods for improved bacterial eradication
Abstract:	A process for treating a bacterial infection with an antibiotic, comprising: administering to a patient with a bacterial infection a product that includes a modified release dosage form containing an antibiotic, said product being administered once-a-day in a dosage and for a number of days that provides a Total T>MIC sufficient to achieve at least the minimum amount of bacterial eradication for treatment of said bacterial infection.
Inventor(s):	Flanner; Henry H. (Montgomery Village, MD), Guttendorf; Robert (Gaithersburg, MD), Treacy; Donald (Woodbine, MD), Clausen; Susan P. (Ijamsville, MD), Burnside; Beth A. (Bethesda, MD)
Assignee:	Shionogi Inc. (Florham Park, NJ)
Application Number:	11/800,574
Patent Claim Types: see list of patent claims	Use; Dosage form; Process;

Drugs Protected by US Patent 8,299,052

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008		DISCN	Yes	No						USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES

International Family Members for US Patent 8,299,052

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006321782
Australia	2006351475
Canada	2635378
Canada	2635606